Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications

.

Source: Expert Opinion on Biological Therapy - July 29, 2020 Category: Drugs & Pharmacology Authors: Subramanian Loganathan Sandeep N. Athalye Shashank R. Joshi Source Type: research